Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum. 1998;41(9):1087–96.
Article CAS PubMed Google Scholar
Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–8. https://doi.org/10.1097/01.sla.0000141194.27992.32.
Article PubMed PubMed Central Google Scholar
Pieniowski EHA, Palmer GJ, Juul T, et al. Low anterior resection syndrome and quality of life after sphincter-sparing rectal cancer surgery: a long-term longitudinal follow-up. Dis Colon Rectum. 2019;62(1):14–20. https://doi.org/10.1097/DCR.0000000000001228.
Denost Q, Laurent C, Capdepont M, Zerbib F, Rullier E. Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum. 2011;54(8):963–8. https://doi.org/10.1097/DCR.0b013e31821d3677.
Smith FM, Rao C, Oliva Perez R, et al. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model. Dis Colon Rectum. 2015;58(2):159–71. https://doi.org/10.1097/DCR.0000000000000281.
Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94(3):351–7. https://doi.org/10.1038/sj.bjc.6602947.
Article CAS PubMed PubMed Central Google Scholar
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D. Corrections to “rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.” Ann Oncol. 2018;29:iv263. https://doi.org/10.1093/annonc/mdy161.
Article CAS PubMed Google Scholar
Scott AJ, Kennedy EB, Berlin J, et al. Management of locally advanced rectal cancer: ASCO guideline. J Clin Oncol. 2024;42(28):3355–75. https://doi.org/10.1200/JCO.24.01160.
Wada Y, Kashida H, Kudo SE, Misawa M, Ikehara N, Hamatani S. Diagnostic accuracy of pit pattern and vascular pattern analyses in colorectal lesions. Dig Endosc. 2010;22(3):192–9. https://doi.org/10.1111/j.1443-1661.2010.00983.x.
Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363–76. https://doi.org/10.1056/NEJMoa2201445.
Article CAS PubMed PubMed Central Google Scholar
Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53(12):1692–8. https://doi.org/10.1007/DCR.0b013e3181f42b89.
Ortega CD, Perez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imag. 2019;10(1):59. https://doi.org/10.1186/s13244-019-0742-6.
Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol. 2008;191(6):1827–35. https://doi.org/10.2214/AJR.08.1004.
Bates DDB, Shaish H, Gollub MJ, Harisinghani M, Lall C, Sheedy SP. Multi-practice survey on MR imaging practice patterns in rectal cancer in the United States. Abdom Radiol (NY). 2022;47(1):28–37. https://doi.org/10.1007/s00261-021-03279-2.
Prata I, Eriksson M, Krdzalic J, et al. Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control. Insights Imag. 2023;14(1):206. https://doi.org/10.1186/s13244-023-01552-0.
Vailati BB, Sao Juliao GP, Habr-Gama A, Perez RO. Nonoperative management of rectal cancer: the watch and wait strategy. Surg Oncol Clin N Am. 2022;31(2):171–82. https://doi.org/10.1016/j.soc.2021.11.003.
Cerdán-Santacruz C, Vailati BB, São GP, Julião AH-G, Perez RO. Watch and wait: why, to whom and how. Surg Oncol. 2022;43:101774. https://doi.org/10.1016/j.suronc.2022.101774.
Battersby NJ, How P, Moran B, et al. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg. 2016;263(4):751–60. https://doi.org/10.1097/SLA.0000000000001193.
Habr-Gama A, Sao Juliao GP, Ortega CD, et al. A multi-centre randomized controlled trial investigating consolidation chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait. BMC Cancer. 2023;23(1):546. https://doi.org/10.1186/s12885-023-10984-2.
Article CAS PubMed PubMed Central Google Scholar
Gerard JP, Barbet N, Schiappa R, et al. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(4):356–67. https://doi.org/10.1016/S2468-1253(22)00392-2.
Article CAS PubMed Google Scholar
Dattani M, Heald RJ, Goussous G, et al. Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018;268(6):955–67. https://doi.org/10.1097/SLA.0000000000002761.
Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–13. https://doi.org/10.1016/S2468-1253(17)30074-2.
Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018. https://doi.org/10.1001/jamaoncol.2018.0071.
Article PubMed PubMed Central Google Scholar
Habr-Gama A, Perez RO, Sabbaga J, Nadalin W, Sao Juliao GP, Gama-Rodrigues J. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum. 2009;52(12):1927–34. https://doi.org/10.1007/DCR.0b013e3181ba14ed.
Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum. 2013;56(10):1109–17. https://doi.org/10.1097/DCR.0b013e3182a25c4e.
Fokas E, Allgauer M, Polat B, et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol. 2019;37(34):3212–22. https://doi.org/10.1200/JCO.19.00308.
Article CAS PubMed Google Scholar
Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–56. https://doi.org/10.1200/JCO.22.00032.
Article CAS PubMed PubMed Central Google Scholar
Alvarez JA, Shi Q, Dasari A, et al. Alliance A022104/NRG-GI010: the janus rectal cancer trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. BMC Cancer. 2024;24(1):901. https://doi.org/10.1186/s12885-024-12529-7.
Article CAS PubMed PubMed Central Google Scholar
Kagawa Y, Ando K, Uemura M, et al. Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2. Ann Gastroenterol Surg. 2024;8(6):1067–75.
Comments (0)